Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
16 p, 1.3 MB Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression / Bosch-Nicolau, Pau (Hospital Universitari Vall d'Hebron) ; Ubals, Maria (Hospital Universitari Vall d'Hebron) ; Salvador, Fernando (Hospital Universitari Vall d'Hebron) ; Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron) ; Aparicio, Gloria (Hospital Universitari Vall d'Hebron) ; Erra Duran, Alba (Hospital Universitari Vall d'Hebron) ; Martínez de Salazar, Pablo (Hospital Universitari Vall d'Hebron) ; Sulleiro Igual, Elena (Hospital Universitari Vall d'Hebron) ; Molina Romero, Israel (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Background Tumor necrosis factor alpha (TNF-α) blockers are recognized as a risk factor for reactivation of granulomatous infections. Leishmaniasis has been associated with the use of these drugs, although few cases have been reported. [...]
2019 - 10.1371/journal.pntd.0007708
PLoS neglected tropical diseases, Vol. 13 Núm. 8 (2019) , p. e0007708  
2.
8 p, 307.5 KB Predictors of biologic treatment of psoriasis : a non-interventional study / Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Fan, Tao (Merck and Co. Global Health Outcomes) ; Ding, Qian (Merck and Co. Global Health Outcomes) ; Smith, Nancy E.. (Merck and Co. Global Health Outcomes) ; Universitat Autònoma de Barcelona
Biologic therapies represent a significant advance in the treatment of psoriasis. However, no studies have examined the patient characteristics predictive of biologic treatment of psoriasis. The purpose of this study was to ascertain the frequency and predictors of treatment of psoriasis with biologics in three European countries, ie, France, Spain, and the UK. [...]
2014 - 10.2147/CEOR.S54797
ClinicoEconomics and outcomes research, Vol. 6 (february 2014) , p. 93-100  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.